{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:33:02Z","timestamp":1788827582627,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The First Affiliated Hospital of Xi\u2019an Jiaotong University","award":["PT002191"],"award-info":[{"award-number":["PT002191"]}]},{"name":"The First Affiliated Hospital of Xi\u2019an Jiaotong University","award":["2024-QN-44"],"award-info":[{"award-number":["2024-QN-44"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05893-2","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T10:16:45Z","timestamp":1733221005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Discovery of novel VEGFR2 inhibitors against non-small cell lung cancer based on fingerprint-enhanced graph attention convolutional network"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3949-4481","authenticated-orcid":false,"given":"Zixiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"7689","key":"5893_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"issue":"1","key":"5893_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"5893_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"5893_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-021-02069-4","volume":"40","author":"C Xie","year":"2021","unstructured":"Xie C, Zhou X, Liang C, Li X, Ge M, Chen Y, et al. Apatinib triggers autophagic and apoptotic cell death via VEGFR2\/STAT3\/PD-L1 and ROS\/Nrf2\/p62 signaling in lung cancer. J Exp Clin Cancer Res. 2021;40(1):266.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5893_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, et al. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22(1):40.","journal-title":"Mol Cancer"},{"issue":"8","key":"5893_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2019.11058","volume":"322","author":"KC Arbour","year":"2019","unstructured":"Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322(8):764\u201374.","journal-title":"JAMA"},{"issue":"8","key":"5893_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345\u201356.","journal-title":"Nat Med"},{"issue":"6","key":"5893_CR8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/joim.13445","volume":"291","author":"M Skribek","year":"2022","unstructured":"Skribek M, Rounis K, Tsakonas G, Ekman S. Complications following novel therapies for non-small cell lung cancer. J Intern Med. 2022;291(6):732\u201354.","journal-title":"J Intern Med"},{"issue":"6","key":"5893_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.apsb.2015.07.008","volume":"5","author":"J Xie","year":"2015","unstructured":"Xie J, Liu J, Liu H, Liang S, Lin M, et al. The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF\/VEGFR2 expression on the human non-small cell lung cancer A549 cell line. Acta Pharm Sin B. 2015;5(6):554\u201363.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"5893_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/molecules28020481","volume":"28","author":"HM Abd El-Lateef","year":"2023","unstructured":"Abd El-Lateef HM, Elbastawesy MAI, Abdelghani Ibrahim TM, Khalaf MM, Gouda M, et al. Design, synthesis, docking study, and antiproliferative evaluation of novel schiff base-benzimidazole hybrids with VEGFR-2 inhibitory activity. Molecules. 2023;28(2):481.","journal-title":"Molecules"},{"issue":"1","key":"5893_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12929-022-00831-0","volume":"29","author":"CY Tsai","year":"2022","unstructured":"Tsai CY, Wu JCC, Wu CJ, Chan SHH. Protective role of VEGF\/VEGFR2 signaling against high fatality associated with hepatic encephalopathy via sustaining mitochondrial bioenergetics functions. J Biomed Sci. 2022;29(1):47.","journal-title":"J Biomed Sci"},{"issue":"4","key":"5893_CR12","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1172\/JCI65385","volume":"123","author":"S Chatterjee","year":"2013","unstructured":"Chatterjee S, Heukamp LC, Siobal M, Sch\u00f6ttle J, Wieczorek C, Peifer M, et al. Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. J Clin Invest. 2013;123(4):1732\u201340.","journal-title":"J Clin Invest"},{"issue":"12","key":"5893_CR13","first-page":"123","volume":"2","author":"C Fontanella","year":"2014","unstructured":"Fontanella C, Ongaro E, Bolzonello S, Guardascione M, Fasola G, Aprile G. Clinical advances in the development of novel VEGFR2 inhibitors. Ann Transl Med. 2014;2(12):123.","journal-title":"Ann Transl Med"},{"issue":"5","key":"5893_CR14","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1111\/cas.14801","volume":"112","author":"H Watanabe","year":"2021","unstructured":"Watanabe H, Ichihara E, Kayatani H, Makimoto G, Ninomiya K, Nishii K, et al. VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers. Cancer Sci. 2021;112(5):1853\u201364.","journal-title":"Cancer Sci"},{"issue":"12","key":"5893_CR15","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S1470-2045(19)30634-5","volume":"20","author":"K Nakagawa","year":"2019","unstructured":"Nakagawa K, Garon EB, Seto T, Nishio M, Ponce Aix S, Paz-Ares L, et al. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019;20(12):1655\u201369.","journal-title":"Lancet Oncol"},{"issue":"1","key":"5893_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41420-022-00818-8","volume":"8","author":"Y Xu","year":"2022","unstructured":"Xu Y, Wang J, Wang X, Zhou X, Tang J, Jie X, et al. Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors. Cell Death Discov. 2022;8(1):36.","journal-title":"Cell Death Discov"},{"issue":"18","key":"5893_CR17","doi-asserted-by":"publisher","first-page":"12651","DOI":"10.1021\/acs.jmedchem.2c01737","volume":"66","author":"A Sadri","year":"2023","unstructured":"Sadri A. Is target-based drug discovery efficient? discovery and \u201coff-target\u201d mechanisms of all drugs. J Med Chem. 2023;66(18):12651\u201377.","journal-title":"J Med Chem"},{"issue":"24","key":"5893_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202102092","volume":"8","author":"Z Ye","year":"2021","unstructured":"Ye Z, Chen F, Zeng J, Gao J, Zhang MQ. ScaffComb: a phenotype-based framework for drug combination virtual screening in large-scale chemical datasets. Adv Sci. 2021;8(24): e2102092.","journal-title":"Adv Sci"},{"key":"5893_CR19","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.2147\/DDDT.S129447","volume":"11","author":"M Szabo","year":"2017","unstructured":"Szabo M, Svensson Akusj\u00e4rvi S, Saxena A, Liu J, Chandrasekar G, Kitambi SS. Cell and small animal models for phenotypic drug discovery. Drug Des Devel Ther. 2017;11:1957\u201367.","journal-title":"Drug Des Devel Ther"},{"issue":"16","key":"5893_CR20","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.1021\/acs.jmedchem.9b00959","volume":"63","author":"Z Xiong","year":"2020","unstructured":"Xiong Z, Wang D, Liu X, Zhong F, Wan X, Li X, et al. Pushing the boundaries of molecular representation for drug discovery with the graph attention mechanism. J Med Chem. 2020;63(16):8749\u201360.","journal-title":"J Med Chem"},{"key":"5893_CR21","doi-asserted-by":"crossref","unstructured":"Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Zhou Z, et al. PubChem\u2019s BioAssay database. Nucleic Acids Res. 2012;40(Database issue):D400\u201312.","DOI":"10.1093\/nar\/gkr1132"},{"issue":"D1","key":"5893_CR22","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2016","unstructured":"Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2016;44(D1):D1075\u20139.","journal-title":"Nucleic Acids Res"},{"key":"5893_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad306","author":"J Gao","year":"2023","unstructured":"Gao J, Shen Z, Xie Y, Lu J, Lu Y, Chen S, et al. TransFoxMol: predicting molecular property with focused attention. Brief Bioinform. 2023. https:\/\/doi.org\/10.1093\/bib\/bbad306.","journal-title":"Brief Bioinform"},{"issue":"1","key":"5893_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1109\/TNNLS.2020.2978386","volume":"32","author":"Z Wu","year":"2021","unstructured":"Wu Z, Pan S, Chen F, Long G, Zhang C, Yu PS. A Comprehensive Survey on Graph Neural Networks. IEEE Trans Neural Netw Learn Syst. 2021;32(1):4\u201324.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"issue":"10","key":"5893_CR25","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1021\/acs.jcim.3c00045","volume":"63","author":"HY Choo","year":"2023","unstructured":"Choo HY, Wee J, Shen C, Xia K. Fingerprint-enhanced graph attention network (FinGAT) model for antibiotic discovery. J Chem Inf Model. 2023;63(10):2928\u201335.","journal-title":"J Chem Inf Model"},{"key":"5893_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107136","volume":"163","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Hu Y, Han N, Yang A, Liu X, Cai H. A survey of drug-target interaction and affinity prediction methods via graph neural networks. Comput Biol Med. 2023;163: 107136.","journal-title":"Comput Biol Med"},{"issue":"8","key":"5893_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009284","volume":"17","author":"X Liu","year":"2021","unstructured":"Liu X, Luo Y, Li P, Song S, Peng J. Deep geometric representations for modeling effects of mutations on protein-protein binding affinity. PLoS Comput Biol. 2021;17(8): e1009284.","journal-title":"PLoS Comput Biol"},{"key":"5893_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2023.102640","volume":"144","author":"Y Zhong","year":"2023","unstructured":"Zhong Y, Zheng H, Chen X, Zhao Y, Gao T, Dong H, et al. DDI-GCN: drug-drug interaction prediction via explainable graph convolutional networks. Artif Intell Med. 2023;144: 102640.","journal-title":"Artif Intell Med"},{"issue":"1","key":"5893_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1109\/TMI.2021.3110829","volume":"41","author":"Y Li","year":"2022","unstructured":"Li Y, Liu J, Jiang Y, Liu Y, Lei B. Virtual adversarial training-based deep feature aggregation network from dynamic effective connectivity for MCI identification. IEEE Trans Med Imaging. 2022;41(1):237\u201351.","journal-title":"IEEE Trans Med Imaging"},{"issue":"9","key":"5893_CR30","first-page":"4935","volume":"44","author":"B Jiang","year":"2022","unstructured":"Jiang B, Wang B, Tang J, Luo B. GeCNs: graph elastic convolutional networks for data representation. IEEE Trans Pattern Anal Mach Intell. 2022;44(9):4935\u201347.","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"5893_CR31","doi-asserted-by":"publisher","unstructured":"Velickovic P, Cucurull G, Casanova A, Romero A, Lio P, Bengio Y. Graph attention networks, ArXiv (2017) abs\/1710.10903. https:\/\/doi.org\/10.48550\/arXiv.1710.10903.","DOI":"10.48550\/arXiv.1710.10903"},{"key":"5893_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106177","volume":"150","author":"M Qiu","year":"2022","unstructured":"Qiu M, Liang X, Deng S, Li Y, Ke Y, Wang P, et al. A unified GCNN model for predicting CYP450 inhibitors by using graph convolutional neural networks with attention mechanism. Comput Biol Med. 2022;150: 106177.","journal-title":"Comput Biol Med"},{"key":"5893_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa243","author":"Z Yu","year":"2021","unstructured":"Yu Z, Huang F, Zhao X, Xiao W, Zhang W. Predicting drug-disease associations through layer attention graph convolutional network. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbaa243.","journal-title":"Brief Bioinform"},{"issue":"23","key":"5893_CR34","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1093\/bioinformatics\/btac676","volume":"38","author":"J Sun","year":"2022","unstructured":"Sun J, Wen M, Wang H, Ruan Y, Yang Q, Kang X, et al. Prediction of drug-likeness using graph convolutional attention network. Bioinformatics. 2022;38(23):5262\u20139.","journal-title":"Bioinformatics"},{"issue":"23","key":"5893_CR35","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1021\/acs.jcim.2c01092","volume":"62","author":"S Wang","year":"2022","unstructured":"Wang S, Chen W, Han P, Li X, Song T. RGN: residue-based graph attention and convolutional network for protein-protein interaction site prediction. J Chem Inf Model. 2022;62(23):5961\u201374.","journal-title":"J Chem Inf Model"},{"issue":"23","key":"5893_CR36","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1021\/acs.jcim.2c01073","volume":"62","author":"D Van Tilborg","year":"2022","unstructured":"Van Tilborg D, Alenicheva A, Grisoni F. Exposing the limitations of molecular machine learning with activity cliffs. J Chem Inf Model. 2022;62(23):5938\u201351.","journal-title":"J Chem Inf Model"},{"key":"5893_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab056","author":"S Wu","year":"2021","unstructured":"Wu S, Fang Z, Tan J, Li M, Wang C, Guo Q, et al. DeePhage: distinguishing virulent and temperate phage-derived sequences in metavirome data with a deep learning approach. Gigascience. 2021. https:\/\/doi.org\/10.1093\/gigascience\/giab056.","journal-title":"Gigascience"},{"issue":"3","key":"5893_CR38","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1109\/JBHI.2021.3109119","volume":"26","author":"Z Chen","year":"2022","unstructured":"Chen Z, Wang X, Huang J, Lu J, Zheng J. Deep attention and graphical neural network for multiple sclerosis lesion segmentation from MR imaging sequences. IEEE J Biomed Health Inform. 2022;26(3):1196\u2013207.","journal-title":"IEEE J Biomed Health Inform"},{"key":"5893_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2022.102329","volume":"130","author":"J Jiang","year":"2022","unstructured":"Jiang J, Wang T, Wang B, Ma L, Guan Y. Gated tree-based graph attention network (GTGAT) for medical knowledge graph reasoning. Artif Intell Med. 2022;130: 102329.","journal-title":"Artif Intell Med"},{"key":"5893_CR40","unstructured":"Gan J, Hu R, Mo Y, Kang Z, Peng L, Zhu Y, et al. Multigraph Fusion for Dynamic Graph Convolutional Network. IEEE Trans Neural Netw Learn Syst. 2022."},{"issue":"6","key":"5893_CR41","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/ph6060700","volume":"6","author":"QA Al-Balas","year":"2013","unstructured":"Al-Balas QA, Amawi HA, Hassan MA, Qandil AM, Almaaytah AM, Mhaidat NM. Virtual lead identification of farnesyltransferase inhibitors based on ligand and structure-based pharmacophore techniques. Pharmaceuticals. 2013;6(6):700\u201315.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"5893_CR42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcc.22885","volume":"33","author":"T Lu","year":"2012","unstructured":"Lu T, Chen F. Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem. 2012;33(5):580\u201392.","journal-title":"J Comput Chem"},{"issue":"5","key":"5893_CR43","doi-asserted-by":"publisher","first-page":"e1606","DOI":"10.1002\/wcms.1606","volume":"12","author":"F Neese","year":"2022","unstructured":"Neese F. Software update: the ORCA program system\u2014version 5.0. WIREs Comput Mol Sci. 2022;12(5):e1606.","journal-title":"WIREs Comput Mol Sci"},{"key":"5893_CR44","unstructured":"Lu T. Sobtop, Version [1.0(dev3.1)]. http:\/\/sobereva.com\/soft\/Sobtop. Accessed 10 Oct 2022."},{"issue":"1","key":"5893_CR45","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12967-023-04443-6","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang Z, Sun L, Xu Y, Liang P, Xu K, Huang J. Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation. J Transl Med. 2023;21(1):579.","journal-title":"J Transl Med"},{"issue":"22","key":"5893_CR46","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1021\/acs.jcim.3c01280","volume":"63","author":"Y Wu","year":"2023","unstructured":"Wu Y, Li K, Li M, Pu X, Guo Y. Attention mechanism-based graph neural network model for effective activity prediction of SARS-CoV-2 main protease inhibitors: application to drug repurposing as potential COVID-19 therapy. J Chem Inf Model. 2023;63(22):7011\u201331.","journal-title":"J Chem Inf Model"},{"issue":"24","key":"5893_CR47","doi-asserted-by":"publisher","first-page":"15219","DOI":"10.1080\/07391102.2023.2188418","volume":"41","author":"L Sun","year":"2023","unstructured":"Sun L, Wang Z, Yang Z, Liu X, Dong H. Virtual screening and structure-activity relationship study of novel BTK inhibitors in traditional Chinese Medicine for the treatment of rheumatoid arthritis. J Biomol Struct Dyn. 2023;41(24):15219\u201333.","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"5893_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1021\/ml500394m","volume":"6","author":"K Okamoto","year":"2015","unstructured":"Okamoto K, Ikemori-Kawada M, Jestel A, von K\u00f6nig K, Funahashi Y, Matsushima T, et al. Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization. ACS Med Chem Lett. 2015;6(1):89\u201394.","journal-title":"ACS Med Chem Lett"},{"issue":"18","key":"5893_CR49","doi-asserted-by":"publisher","first-page":"10259","DOI":"10.3390\/ijms231810259","volume":"23","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Yang H, Wu F, Luo X, Sun Q, Feng W, et al. Exploration of N-arylsulfonyl-indole-2-carboxamide derivatives as novel fructose-1,6-bisphosphatase inhibitors by molecular simulation. Int J Mol Sci. 2022;23(18):10259.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5893_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0969-2126(99)80042-2","volume":"7","author":"MA McTigue","year":"1999","unstructured":"McTigue MA, Wickersham JA, Pinko C, Showalter RE, Parast CV, Tempczyk-Russell A, et al. Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis. Structure. 1999;7(3):319\u201330.","journal-title":"Structure"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05893-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05893-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05893-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:04:49Z","timestamp":1733223889000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05893-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5893"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05893-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"11 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors of this article agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1097"}}